Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

15.01.2024

1 Am J Obstet Gynecol
1 Am J Respir Crit Care Med
1 Ann Intern Med
2 Antiviral Res
5 BMJ
1 Clin Infect Dis
4 Emerg Infect Dis
1 J Infect
7 J Med Virol
2 J Travel Med
3 J Virol
4 JAMA
4 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
1 Radiol Imaging Cancer
1 Radiology
1 Science



    Am J Obstet Gynecol

  1. FRYAR C, Mouro S, Whiteside JL, Tumin D, et al
    Effect of COVID-19 Pandemic on Same Day Discharge for Elective Benign Hysterectomy.
    Am J Obstet Gynecol. 2024 Jan 3:S0002-9378(24)00001.
    >> Share


    Am J Respir Crit Care Med

  2. KERCHBERGER VE
    Host Response to Infection: Not All Lymphopenia Is Created Equal in SARS-CoV-2.
    Am J Respir Crit Care Med. 2024 Jan 8. doi: 10.1164/rccm.202312-2265.
    >> Share


    Ann Intern Med

  3. WU Q, Tong J, Zhang B, Zhang D, et al
    Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents.
    Ann Intern Med. 2024 Jan 9. doi: 10.7326/M23-1754.
    >> Share


    Antiviral Res

  4. GOVEDNIK T, Lainscek D, Kuhar U, Lachish M, et al
    TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower inflammatory consequences.
    Antiviral Res. 2024 Jan 9:105806. doi: 10.1016/j.antiviral.2024.105806.
    >> Share

  5. GARCIA-RODRIGUEZ I, Moreni G, Capendale PE, Mulder L, et al
    Assessment of the broad-spectrum host targeting antiviral efficacy of halofuginone hydrobromide in human airway, intestinal and brain organotypic models.
    Antiviral Res. 2024 Jan 6:105798. doi: 10.1016/j.antiviral.2024.105798.
    >> Share


    BMJ

  6. O'DOWD A
    Covid-19 has cut UK life expectancy by around half a year, data suggest.
    BMJ. 2024;384:q78.
    >> Share

  7. MAHASE E
    Covid-19: NICE plans to expand Paxlovid eligibility to 1.4 million more people.
    BMJ. 2024;384:q59.
    >> Share


  8. Update to living systematic review on SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission.
    BMJ. 2024;384:p2929.
    >> Share

  9. SLAUNWHITE A, Min JE, Palis H, Urbanoski K, et al
    Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study.
    BMJ. 2024;384:e076336.
    >> Share

  10. TANNE JH
    Covid-19: Some US states and hospitals recommend masks again.
    BMJ. 2024;384:q26.
    >> Share


    Clin Infect Dis

  11. NACHMAN S, Aldrovandi G
    Breastfeeding in the United States Among Women With HIV: Con Viewpoint.
    Clin Infect Dis. 2024 Jan 8:ciad778. doi: 10.1093.
    >> Share


    Emerg Infect Dis

  12. BAI Y, Du Z, Wang L, Lau EHY, et al
    Public Health Impact of Paxlovid as Treatment for COVID-19, United States.
    Emerg Infect Dis. 2024;30.
    >> Share

  13. JEON S, Watson-Lewis L, Rainisch G, Chiu CC, et al
    Adapting COVID-19 Contact Tracing Protocols to Accommodate Resource Constraints, Philadelphia, Pennsylvania, USA, 2021.
    Emerg Infect Dis. 2024;30.
    >> Share

  14. EALES O, Plank MJ, Cowling BJ, Howden BP, et al
    Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 Pandemic.
    Emerg Infect Dis. 2024;30.
    >> Share

  15. EGBELOWO OF, Fox SJ, Gibson GC, Meyers LA, et al
    Model for Interpreting Discordant SARS-CoV-2 Diagnostic Test Results.
    Emerg Infect Dis. 2024;30.
    >> Share


    J Infect

  16. ZHANG H, Zhou K, Peng F, Gao Z, et al
    Novel small-molecule inhibitors of SARS-CoV-2 main protease with nanomolar antiviral potency.
    J Infect. 2024 Jan 6:S0163-4453(23)00600-X. doi: 10.1016/j.jinf.2023.
    >> Share


    J Med Virol

  17. HU L, Yang Y, Lin J, Yan Q, et al
    Epidemiological characteristics of respiratory syncytial virus infection in pediatric patients before, during the COVID-19 pandemic and after easing of COVID-19 restrictive measures in China.
    J Med Virol. 2024;96:e29374.
    >> Share

  18. ZHANG Y, Ma Y, Sun W, Zhou X, et al
    Exploring gut-lung axis crosstalk in SARS-CoV-2 infection: Insights from a hACE2 mouse model.
    J Med Virol. 2024;96:e29336.
    >> Share

  19. FAVRESSE J, Gillot C, Closset M, Cabo J, et al
    Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster.
    J Med Virol. 2024;96:e29365.
    >> Share

  20. CHOI CY, Gadhave K, Villano J, Pekosz A, et al
    Generation and characterization of a humanized ACE2 mouse model to study long-term impacts of SARS-CoV-2 infection.
    J Med Virol. 2024;96:e29349.
    >> Share

  21. LEE HM, Shih PC, Wei JC
    Comment on Shao et al.'s "Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic".
    J Med Virol. 2024;96:e29383.
    >> Share

  22. LI J, Zhang K, Lin G, Li J, et al
    CRISPR-Cas system: A promising tool for rapid detection of SARS-CoV-2 variants.
    J Med Virol. 2024;96:e29356.
    >> Share

  23. CAPELLI N, Domitien Payet L, Alcocer Cordellat C, Pisoni A, et al
    SARS-CoV-2 nucleocapsid antigen in plasma of children hospitalized for COVID-19 or with incidental detection of SARS-CoV-2 infection.
    J Med Virol. 2024;96:e29358.
    >> Share


    J Travel Med

  24. MOORE JE, Millar BC
    Improving health literacy of passengers of cruise ships: readability of passenger-facing COVID-19 information provided by commercial cruise lines-an infodemiology study.
    J Travel Med. 2024 Jan 11:taae006. doi: 10.1093.
    >> Share

  25. JAMES ER, Church LWP, Hoffman SL, Robertson BD, et al
    Piloting delivery of PfSPZ vaccines for malaria through a cryogenic vaccine cold chain to travel and military medicine clinics.
    J Travel Med. 2024 Jan 11:taae007. doi: 10.1093.
    >> Share


    J Virol

  26. DULIN H, Barre RS, Xu D, Neal A, et al
    Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.
    J Virol. 2024 Jan 11:e0157123. doi: 10.1128/jvi.01571.
    >> Share

  27. BERTZBACH LD, Seddar L, von Stromberg K, Ip W-H, et al
    The adenovirus DNA-binding protein DBP.
    J Virol. 2024 Jan 10:e0188523. doi: 10.1128/jvi.01885.
    >> Share

  28. YIN L, Liu X, Yao Y, Yuan M, et al
    Gut microbiota-derived butyrate promotes coronavirus TGEV infection through impairing RIG-I-triggered local type I interferon responses via class I HDAC inhibition.
    J Virol. 2024 Jan 10:e0137723. doi: 10.1128/jvi.01377.
    >> Share


    JAMA

  29. MARKS P, Califf R
    Is Vaccination Approaching a Dangerous Tipping Point?
    JAMA. 2024 Jan 5. doi: 10.1001/jama.2023.27685.
    >> Share

  30. KAPOOR N, Dietz C, Buettner BP
    An Incarcerated Individual With Weight Loss and Interstitial Pulmonary Infiltrates.
    JAMA. 2024 Jan 8. doi: 10.1001/jama.2023.24260.
    >> Share

  31. RUBIN R
    From "Immunity Debt" to "Immunity Theft"-How COVID-19 Might Be Tied to Recent Respiratory Disease Surges.
    JAMA. 2024 Jan 10. doi: 10.1001/jama.2023.26608.
    >> Share

  32. RUBIN R
    As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2 "Variant of Interest".
    JAMA. 2024 Jan 12. doi: 10.1001/jama.2023.27841.
    >> Share


    Lancet Infect Dis

  33. COSSMANN A, Hoffmann M, Stankov MV, Lurken K, et al
    Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany.
    Lancet Infect Dis. 2024 Jan 8:S1473-3099(23)00783.
    >> Share

  34. KOSUGI Y, Kaku Y, Hinay AA Jr, Guo Z, et al
    Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals.
    Lancet Infect Dis. 2024 Jan 8:S1473-3099(23)00784.
    >> Share

  35. HANSEN CH, Moustsen-Helms IR, Rasmussen M, Soborg B, et al
    Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study.
    Lancet Infect Dis. 2024 Jan 5:S1473-3099(23)00746.
    >> Share

  36. KAKU Y, Okumura K, Padilla-Blanco M, Kosugi Y, et al
    Virological characteristics of the SARS-CoV-2 JN.1 variant.
    Lancet Infect Dis. 2024 Jan 3:S1473-3099(23)00813.
    >> Share


    MMWR Morb Mortal Wkly Rep

  37. PAYNE AB, Novosad S, Wiegand RE, Najdowski M, et al
    Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged >/=65 Years and Those with End Stage Renal Disease - United States, September 2022-March 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:16-23.
    >> Share


    Radiol Imaging Cancer

  38. CHOI HH, Kim S, Shum DJ, Huang CY, et al
    Assessing Adherence to US LI-RADS Follow-up Recommendations in Vulnerable Patients Undergoing Hepatocellular Carcinoma Surveillance.
    Radiol Imaging Cancer. 2024;6:e230118.
    >> Share


    Radiology

  39. CHA MJ, Solomon JJ, Lee JE, Choi H, et al
    Chronic Lung Injury after COVID-19 Pneumonia: Clinical, Radiologic, and Histopathologic Perspectives.
    Radiology. 2024;310:e231643.
    >> Share


    Science

  40. COHEN J
    Covid's cold cousins.
    Science. 2024;383:141-145.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016